PURPOSE: Administrative healthcare databases are used for health services research, comparative effectiveness studies, and measuring quality of care. Adjustment for comorbid illnesses is essential to such studies. Validation of methods to account for comorbid illnesses in administrative data for patients with chronic obstructive pulmonary disease (COPD) has been limited. Our objective was to compare the ability of the Charlson index, the Elixhauser method, and the Johns Hopkins' Aggregated Diagnosis Groups (ADGs) to predict outcomes in patients with COPD. METHODS: Retrospective cohorts constructed using population-based administrative data of patients with incident (n = 216,735) and prevalent (n = 638,926) COPD in Ontario, Canada, were divided into derivation and validation datasets. The primary outcome was all-cause death within 1 year. Secondary outcomes included all-cause hospitalization, COPD-specific hospitalization, non-COPD hospitalization, and COPD exacerbations. RESULTS: In both the incident and prevalent COPD cohorts, the three methods had comparable discrimination for predicting mortality (c-statistics in the validation sample of incident patients of 0.819 for the Charlson method versus 0.822 for the Elixhauser method versus 0.830 for the ADG method). All three methods had lower predictive accuracy for predicting nonfatal outcomes. CONCLUSIONS: In a disease-specific cohort of COPD patients, all three methods allowed for accurate prediction of mortality, with the Johns Hopkins ADGs having marginally higher discrimination.
PURPOSE: Administrative healthcare databases are used for health services research, comparative effectiveness studies, and measuring quality of care. Adjustment for comorbid illnesses is essential to such studies. Validation of methods to account for comorbid illnesses in administrative data for patients with chronic obstructive pulmonary disease (COPD) has been limited. Our objective was to compare the ability of the Charlson index, the Elixhauser method, and the Johns Hopkins' Aggregated Diagnosis Groups (ADGs) to predict outcomes in patients with COPD. METHODS: Retrospective cohorts constructed using population-based administrative data of patients with incident (n = 216,735) and prevalent (n = 638,926) COPD in Ontario, Canada, were divided into derivation and validation datasets. The primary outcome was all-cause death within 1 year. Secondary outcomes included all-cause hospitalization, COPD-specific hospitalization, non-COPD hospitalization, and COPD exacerbations. RESULTS: In both the incident and prevalent COPD cohorts, the three methods had comparable discrimination for predicting mortality (c-statistics in the validation sample of incident patients of 0.819 for the Charlson method versus 0.822 for the Elixhauser method versus 0.830 for the ADG method). All three methods had lower predictive accuracy for predicting nonfatal outcomes. CONCLUSIONS: In a disease-specific cohort of COPD patients, all three methods allowed for accurate prediction of mortality, with the Johns Hopkins ADGs having marginally higher discrimination.
Authors: Nicholas R Anthonisen; Melissa A Skeans; Robert A Wise; Jure Manfreda; Richard E Kanner; John E Connett Journal: Ann Intern Med Date: 2005-02-15 Impact factor: 25.391
Authors: D M Mannino; G Watt; D Hole; C Gillis; C Hart; A McConnachie; G Davey Smith; M Upton; V Hawthorne; D D Sin; S F P Man; S Van Eeden; D W Mapel; J Vestbo Journal: Eur Respir J Date: 2006-03 Impact factor: 16.671
Authors: Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali Journal: Med Care Date: 2005-11 Impact factor: 2.983
Authors: A Sonia Buist; Mary Ann McBurnie; William M Vollmer; Suzanne Gillespie; Peter Burney; David M Mannino; Ana M B Menezes; Sean D Sullivan; Todd A Lee; Kevin B Weiss; Robert L Jensen; Guy B Marks; Amund Gulsvik; Ewa Nizankowska-Mogilnicka Journal: Lancet Date: 2007-09-01 Impact factor: 79.321
Authors: Dan R Berlowitz; Helen Hoenig; Diane C Cowper; Pamela W Duncan; W Bruce Vogel Journal: Arch Phys Med Rehabil Date: 2008-10 Impact factor: 3.966
Authors: Madhur Nayan; Robert J Hamilton; Antonio Finelli; Peter C Austin; Girish S Kulkarni; David N Juurlink Journal: Can Urol Assoc J Date: 2017-06 Impact factor: 1.862
Authors: Christopher C D Evans; Yvonne DeWit; Dallas Seitz; Stephanie Mason; Avery Nathens; Stephen Hall Journal: CMAJ Date: 2018-11-12 Impact factor: 8.262
Authors: Jennifer Hornung Garvin; Andrew Redd; Dan Bolton; Pauline Graham; Dominic Roche; Peter Groeneveld; Molly Leecaster; Shuying Shen; Mark G Weiner Journal: Perspect Health Inf Manag Date: 2013-10-01
Authors: Young Ji Lee; Andrew D Boyd; Jianrong John Li; Vincent Gardeux; Colleen Kenost; Don Saner; Haiquan Li; Ivo Abraham; Jerry A Krishnan; Yves A Lussier Journal: AMIA Annu Symp Proc Date: 2014-11-14
Authors: Tetyana Kendzerska; Carl van Walraven; Daniel I McIsaac; Marcus Povitz; Sunita Mulpuru; Isac Lima; Robert Talarico; Shawn D Aaron; William Reisman; Andrea S Gershon Journal: Clin Epidemiol Date: 2021-06-17 Impact factor: 4.790